Decibel
Therapeutics is a Massachusetts-based biotechnology company that researches and develops drugs for the treatment of ear, nose, and throat diseases... Read moreDecibel
Therapeutics is a Massachusetts-based biotechnology company that researches and develops drugs for the treatment of ear, nose, and throat diseases... Read more
News
Apr 17, 2024
Pharamceutical Technology
Decibel: Decibel Therapeutics gets grant for hypertonic pharmaceutical composition for anti-platinum chemoprotection
Mar 11, 2024
Pharamceutical Technology
Decibel: Decibel Therapeutics files patent for cell lines expressing crispr sam complex for gene activation
Sep 25, 2023
BioSpace
Decibel: Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss
Sep 25, 2023
MarketScreener
Decibel: Decibel Therapeutics : Acquisition/Asset Disposal - Form 8-K
Sep 25, 2023
MarketScreener
Decibel: Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped from S&P TMI Index
Aug 14, 2023
Pharmaceutical Processing World
Decibel: Regeneron agrees to spend up to $213M to acquire Decibel Therapeutics
Aug 12, 2023
Life Care News
Decibel: Decibel Therapeutics Reports Second Quarter 2023 Financial
Aug 12, 2023
Acrofan
Decibel: WESTERN ASSET INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Propose
Aug 11, 2023
Global Legal Chronicle
Decibel: Regeneron's Acquisition of Decibel Therapeutics
Aug 09, 2023
The Business Journals
Decibel: Regeneron to buy Boston-based hearing loss biotech for $213M
Decibel Competitors
1
2
3
4
5
6
7
8
9
10